In May, Synpromics attended the ASGCT annual general meeting in Chicago. After a slightly delayed arrival of the exhibition stands (having got temporarily lost somewhere over the Atlantic!), the Synpromics delegation enjoyed a few days of interesting presentations around the future of gene and cell therapy, as well as making some great connections with fellow biotech professionals. Synpromics were also able to introduce numerous booth visitors to a renowned Scottish delicacy, the Tunnocks Teacake – 500 were consumed over the course of the conference!
Whilst there, Synpromics presented a poster entitled “A Novel Genomics-Based Platform for the Creation of Environmental-Responsive Gene Promoters”. It introduced the company’s novel genomics-based platform, PromPT, that facilitates the design, synthesis and testing of mammalian gene regulatory elements, the output of which supports the creation of next generation cell and gene therapeutics. The poster included data showing these promoters active in a number of different cell types with large, dynamic ranges of activity. The full poster can be viewed here.
Synpromics also hosted a standing room only scientific symposium, “Next Generation Gene Medicine – Leveraging synthetic promoters in product design”, attended by over 230 delegates. It featured speakers from key Synpromics partners, including: AGTC, AskBio, Homology Medicines, Solid Biosciences and uniQure, which sparked a fascinating panel discussion covering gene therapy and the various ways synthetic promoters can be used in the future of gene medicine. Click here to view Dr Michael Robert’s presentation from the symposium.
After a successful couple of days in Chicago, Synpromics are already looking forward to next year’s ASGCT meeting! For more information on Synpromics’ current research on synthetic promoters in gene and cell therapy click here or get in touch.
Sarah Haecker Meeks, PhD
VP, Business Development
T: (+1) 612-202-6805